The clinical benefits and cost effectiveness and safety of haematopoietic interventions for patients with anaemia following major emergency surgery: a phase IV, multi-site, multi-arm randomised controlled trial: Peri-op Iron and Erythropoietin (EPO) Intervention Study (POP-I)

Research summary

Multisite,multi-arm,open-label,pragmatic randomised controlled trial with integral internal pilot and concurrent economic evaluation. The trial is predicated on two primary comparisons of (1) a monotherapy (i.e. Iron) and (2) a combination therapy (i.e. Iron + EPO),compared with a single common control group (usual care) respectively,in a superiority hypothesis testing framework.

Principal Investigator

Shvaita Ralhan

Contact us

Email: Kathryn.Lewis@ouh.nhs.uk

IRAS number

1007432